Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight

Frontiers in Immunology(2023)10.3389/fimmu.2023.1208828Source: DataRank Database

Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.09)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Chulbul M. Ahmed,Howard M. Johnson ORCID

Live enrichment

PubMed:38106428 PMC:PMC10722180 OpenAlex:https://openalex.org/W4389236142

NIAID NIH HHS

Grant: R01 AI056152

NIAID NIH HHS

Grant: R56 AI056152

National Institutes of Health

Grant: 2R01AI056152-05A2

Study of gamma interferon agonists/mimetics

FWCI

0.09

Citation Percentile

0.4%

Citation Trend

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1208828/pdf?isPublishedV2=False

GOLDhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1208828/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1208828/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1208828/full

journalhttps://doi.org/10.3389/fimmu.2023.1208828

Fields of Study

interferon and immune responsesSARS-CoV-2 and COVID-19 ResearchCytokine Signaling Pathways and InteractionsMedicine0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Suppressor of Cytokine Signaling 1 ProteinCOVID-19SARS-CoV-2Antiviral AgentsHumansInterferon Type IRNA, ViralMpox, MonkeypoxMpox (monkeypox)Suppressor of Cytokine Signaling ProteinsPeptidomimeticsPandemics

Keywords

VirologyPandemicVirusPeptidomimeticBiologyViral pneumoniaImmunologyMedicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)InterferonCoronavirusAntiviralsMonkeypox VirusSocs AntagonistSARS-CoV-2COVID-19Suppressor of Cytokine Signaling ProteinsRC581-607Antiviral AgentsMpox, MonkeypoxSuppressor of Cytokine Signaling 1 ProteinInterferon Type IHumansRNA, ViralPeptidomimeticsImmunologic diseases. AllergyPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being